We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to select compliance points for the assessment of risks to groundwater from land contamination.
The government responds to a report by the Advisory Council on the Misuse of Drugs and commissions Part 2 of work on barriers to research.
Receptor recognition and binding is the first step of viral infection and a key determinant of host specificity.
This report provides an updated harms assessment to the ACMD's previous reports on synthetic cannabinoid receptor agonists.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Associations of inherited blood disorders and hemoglobin, ferritin and soluble transferrin receptor concentrations
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
When you need to do an environmental risk assessment, when the Environment Agency will do it for you, and how to do a risk assessment.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).